Guided Imagery for PTSD
(PTSD Trial)
Trial Summary
What is the purpose of this trial?
Post-Traumatic Stress Disorder (PTSD) affects a significant portion of the population, with about 13 million Americans diagnosed in 2020. Women are twice as likely to have PTSD than men. PTSD will affect 8%, or 8 out of every 100 women, at some stage in their lives. This study will check the effects of guided imagery mindfulness on PCL-5 scores in adult women with PTSD. Participants in this study will complete a PCL-5 pre-test and post-test to check PTSD symptoms before and after 6-weeks of mindfulness sessions. Each participant will engage in 15-minute sessions of guided imagery mindfulness once a week for 6 weeks. Before and after PCL-5 scores will show the effect of guided imagery mindfulness on PTSD symptom severity.
Eligibility Criteria
This trial is for adult women who have been diagnosed with Post-Traumatic Stress Disorder (PTSD). They should be willing to participate in guided imagery mindfulness sessions once a week for six weeks and complete pre- and post-tests to measure their PTSD symptoms.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in 15-minute sessions of guided imagery mindfulness once a week for 6 weeks
Follow-up
Participants complete a post-intervention PCL-5 questionnaire to evaluate changes in PTSD symptom severity
Treatment Details
Interventions
- Guided Imagery
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nova Southeastern University
Lead Sponsor